Declining estimates of infertility in the United States: 1982-2002. Fertil Steril 2006;86:516-523.
Delaying childbearing: effect of age on fecundity and outcome of pregnancy. BMJ 1991;302:1361-1365.
The time is now for a new approach to primary ovarian insufficiency. Fertil Steril 2012;95:1890-1897.
Systemic adversities of ovarian failure. J Soc Gynecol Investig 2001;8:S7-S9.
Is early natural menopause a biologic marker of health and aging? Am J Public Health 1989;79:709-714.
Present and future options for the preservation of fertility in female adolescents with cancer. Endocr Dev 2005;8:166-175.
A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology 1938;23:566.
The effect of smoking on oogenesis, fertilization and implantation. Semin Reprod Endocrinol 1989;7:291-304.
Effect of smoking on ovarian reserve and ovarian stimulation in in vitro fertilization and embryo transfer. Hum Reprod 1998;13:2192-2198.
Constituents of cigarette smoke inhibit human granulosa cell aromatase. Fertil Steril 1986;46:232-236.
Vanderburgh. Pregnancy after uterine artery embolization for leiomyomata: The Ontario Multicenter Trial. Obstet Gynecol 2005;105:67-76.
Premature ovarian failure. In: Adashi EY, Rock JA, Rosenwaks Z, editors. Reproductive endocrinology, surgery and technology. Philadelphia: Lippincott-Raven 1996;1393-1410.
Clinical features of young women with hyper-gonadotropic amenorrhea. Fertil Steril 1990;53:804-810.
Premature ovarian failure in galactosaemia: pathophysiology and clinical management. Pathol Biol (Paris) 2003;51:47-56.
Ovulation induction with clomiphene citrate in a woman with premature ovarian failure. A case report. J Reprod Med 1988;33:559-562.
Mumps oophoritis: a cause of premature menopause. Fertil Steril 1975;26:655-659.
Ovarian function before and after salpingectomy in artificial reproductive technology patients. Hum Reprod 2000;15:142-144 (level II-3).
Prophylactic salpingectomy does not impair the ovarian response in IVF treatment. Hum Reprod 2001161135-113. (level I).
Environmental toxicants and female reproduction. Fertil Steril 1998;70:613-622.
The follicle-stimulating hormone receptor gene is polymorphic in premature ovarian failure and normal controls. Fertil Steril 1995;64:518-524.
Oocyte apoptosis: like sand through an hourglass. Dev Biol 1999;213:1-17.
Evaluation and treatment of low responders in assisted reproductive technique: a challenge to meet. J Assist Reprod Genet 2000;17:357-373.
Optimum number of oocytes for a successful first IVF treatment cycle. Reprod Biomed Online 2006;13:476-480.
Factors that affect outcome of in vitro fertilization. Lancet 1996;348:1402-1406.
Poor responders to ovulation induction: is proceeding to in vitro fertilization worthwhile? Hum Reprod 1999;14:964-969.
Strategies for ascertaining ovarian reserve among women suspected of subfertility. Int J Fertil Womens Med 2000;45:215-224.
Intercycle variability of ovarian reserve tests: results of a prospective randomized study. Hum Reprod 2004;19:590-595.
A moderately elevated day 3 FSH concentration has limited predictive value, especially in younger women. Hum Reprod 2002;17:118-123.
The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal follicle-stimulating hormone. Fertil Steril 2008;89:868-878.
Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization. Fertil Steril 2005;83:37-41.
Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril 1995;64:1136-1140.
High reproducibility of serum anti-mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 2005;20:923.
Serum antimullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002;17:3065-3071.
Anti-mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010;16:113-130.
ESHRE consensus on the definition of ‘poor response ‘to ovarian stimulation for in vitro fertilization: the bologna criteria. Hum Reprod 2011;26: 1616-1624.
Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population. Hum Reprod 2007;22:778-785.
Ultrasound tests of ovarian reserve: a systematic review of accuracy in predicting fertility outcomes. Human Fertility 2009;12(2):95-106.
The clomiphene citrate challenge test for the prediction of poor ovarian response and non-pregnancy in patients undergoing in vitro fertilization: a systematic review. Fertil Steril 2006;86: 807-818.
Ovarian reserve assessment for infertility investigation. ISRN Obstet Gynecol 2012;2012:576385. doi: 10.5402/2012/576385. Epub 2012 Jan 26.
Dynamic tests of ovarian reserve: a systematic review of diagnostic accuracy. Reproductive BioMedicine Online 2009;18(5):717-734.
A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685-718.
ESHRE consensus on the definition of poor response to ovarian stimulation for in vitro fertilization: the bologna criterion. Hum Reprod 2011;26: 1616-1624.
Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization. Fertil Steril 1987;48:964-968.
Doubling the dose of human menopausal gonadotropin in course of in vitro fertilization treatment cycle in poor responder: a randomized study. Human Reprod 1993;8: 369-373.
Microdose follicular phase gonadotropin releasing hormone agonist compared with luteal phase agonist for ovarian stimulation in in vitro fertilization. Fertil Steril 1999;72: 1018-1023.
A controlled trial of natural cycle versus microdose GnRH flare cycles in poor responders undergoing invitro fertilization. Fertil Steril 2004;81: 1542-1547.
Gonadotropin and gonadotropin receptors during the perimenopause. Eur J Endocrinol Metab 2003;88:3327-3332.
Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev 2007:CD005070.
Effect of androgen levels on in vitro fertilization cycles. Fertil Steril 2004;81:1713-1714.
The effect of transdermal testosterone gel pre-treatment on controlled ovarian stimulation and IVF outcome in poor responders. Fertil Steril 2011;95: 679-683.